In DM mouse model, we also found that the levels of GLP-1 and GIP in serum and protein expression levels of GLP-1R and GIPR were reduced significantly, and CHS treatment could restore their expression levels in vitro and in vivo. The gene discussed is GIPR; the disease is diabetes mellitus.